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What Is an Adverse Health Effect?
by Russell P. Sherwin*
Health is defined as homeostasis ofthe cellular ecology, and a state where there has not
been an inordinate loss, reversible or irreversible, of the structural and/or functional
reserves of the body. An adverse health effect is defined as the causation, promotion,
facilitation and/or exacerbation of a structural and/or functional abnormality, with the
implication that the abnormality produced has the potential of lowering the quality of
life, contributing to a disabling illness, or leading to a premature death. Experimental
animal studies indicate that poor air quality has the potential for serious adverse health
effects through perturbations ofthe cellular ecology over long-term periods. Some ofthe
most important concerns are inordinate depletions of lung reserves (in particular, em-
physema), thefacilitation ofcancermetastasis to the lung, the facilitation ofimmunologic
deficits with the concomitant expression ofopportunistic organisms, and amplification of
cardiovascular abnormalities (in particular, ischemic heart disease). It is argued that air
quality standard setting should more strongly consider adverse health effects that are
presently subclinical in nature in order to achieve early prevention instead of late
correction.
A definition ofadverse health effect is a begin-
ning step towards assistance in the establishment
ofreasonable air quality standards. As a part of
thatdefinition, consideration mustbe giventothe
question, what is health. Defining health is not
an academic exercise, since there is no sharp line
between a normal state ofhealth and subclinical
diseases. For example, some degree of coronary
artery disease and emphysema is essentially
ubiquitous in the adult "well population," and
there is in fact a progressive deterioration of
health with time and not necessarily in accord-
ance with age. Within the health-disease spec-
trum there are four basic categories of adverse
effects on health. The end stage category, death,
provides mortality data that are relatively insen-
sitive for assistance in the setting of air quality
standards. Moreover, mortality rate increases
that are acute, as occurred in the London episodes
ofthe 1950s, and long-term rises, as for example
the 20-30 year delayed mortality increase oflung
cancer secondary to cigarette smoking and asbes-
tos exposure, are obviouslyprohibitive sources for
future air quality data. The category ofmorbidity
ranges from the earliest or mildest symptoms of
ill health to exacerbations ofterminal illnesses of
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diverse kinds. Morbidity data can and does pro-
vide useful data for air quality evaluation, but,
again, at a level that is often less sensitive than
required, or ifhighly sensitive, e.g., eye irritation
in a highly susceptible individual, may not be
considered to be a significant health hazard. A
third category is subclinical disease or morbility
(1), i.e., the patient either does not have symp-
toms or fails to recognize them, and the level of
sensitivity ofclinical tests is inadequate for diag-
nosis. This category is an especially important
and largely neglected source ofdata for air qual-
ity evaluation. A majority, ifnot most ofthe adult
well population has some form ofchronic disease
at a subclinical level, ranging from early lesions
to nascent clinical disease. Improvements and
new developments in clinical testing are urgently
needed to openup the greater part ofthe category
of morbility to clinical recognition, especially
with respect to the major chronic diseases and the
needs of air quality control. The fourth category
of adverse health effects has been all but over-
looked insofar as air quality standards are con-
cerned, namely, a state ofhealth where there has
been an inordinate depletion of cell, tissue, and
organ reserves, or so-called hypeinopenia (1). Re-
serve loss involves both reversible and irrevers-
ible alterations of cell population and includes
metabolic abnormalities and alterations of theR. P. SHERWIN
intercellular milieu. In actuality, the earliest ad-
verse health effect is an altered ecology at the
cellular level. Extraordinarily serious alterations
may be sustained at this level without coming to
clinical attention until structural and functional
loss reaches an end-stage, as will be discussed
with respect to emphysema. Thus, definitions of
health and of adverse health effect must start
with a consideration of the human body as an
ecologic entity comprised of multitudinous cell
societies.
What Is Health?
Over 30 years ago, the World Health Organiza-
tion (2) defined health as a "state of complete
physical, mental, and social well-being, and not
merely the absence of disease or infirmity." As
Callahan stated (2), the definition puts "medicine
and society in the untenable position of being
required to obtain unobtainable goals." No other
definition has since been made available, at least
not for air quality control consideration. The im-
mediate relevancy ofdefining health for standard
setting purposes is that the well population may
not be as well as presently believed, and this
would mean a far larger subpopulation ofsuscep-
tible individuals than is presently appreciated.
As implied earlier, the question of susceptible
subpopulations must ultimately focus largely on
cellular inventories, i.e., the structural and func-
tional reserves ofthe cell societies and their envi-
rons that constitute the human ecology at the
cellular level. Health, then, is fundamentally ho-
meostasis of the cellular ecology, and a state
where there has notbeen an inordinate reversible
or irreversible loss ofreserves.
What Is the Present Level of
Health?
There is the impression that we are becoming
progressively healthier, due mainly to better nu-
trition, sanitation, medical care, and personal
hygiene. Germanely, vital statistics indicate that
life expectancy at the time of birth extended to
73.6 years in 1980 (3). However, the number of
years oflife remaining at the age of45 in 1980 is
not remarkably different from the 1900 figure,
i.e., 24.8 years versus 32.1 years, or a gain of 7.1
years (4). Moreover, life expectancy for those at
age 75 has increased by only 3 years over the 80-
year study period. In effect, there may be some
gain for adults (3), but the longevity indicator is
largely reflecting better neonatal and child care
(4). There is another indicator that also cautions
against an optimistic view ofthe general health,
namely the incidence of disability. Coldez and
Blanchet (5) have called attention to a substan-
tial increase in disability, 30% versus a 10% in-
crease in the population. Very disconcertingly,
the increase in disability included the younger
and middle age groups, and the investigators
concluded that environmental factors may in part
be responsible for the increased incidence. A de-
tailed treatment ofthe question "Do health indi-
cators indicate health?" as cogently posed by
Wilson (6), can be found in a Daedalus review (7).
What Is the Present Level of
Health with Respect to the Lung?
The importance ofthe lungto health is ofmuch
greater magnitude than has been previously ap-
preciated. For example, diverse metabolic activi-
ties have been identified in the lung and they
warrant calling the lung an endocrine organ (8).
Tb date, air quality studies have paid relatively
little attention to pollutant-induced perturba-
tions of the lung's diverse metabolic activities.
From a clinical standpoint, the lung is gaining
greater attention as a major health problem. The
incidence of chronic obstructive pulmonary dis-
ease (COPD) is said to be quadrupling every 5
years, the trendbeginning 15 years ago (9). There
has alsobeen aremarkable increase inthe discov-
ery of"new" lung diseases. Of special pertinence
to air quality, many ofthe newly uncovered lung
diseases are environmentally related, e.g., the
ever growing list of hypersensitivity lung dis-
eases (10), silicate pneumoconiosis (11, 12), and
Legionnaire's disease (13). Moreover, the real im-
pact on the community ofsome ofthe well-known
dust hazards has yet to be established, in particu-
lar the ubiquitous occurrence of asbestos in the
lungs ofthe well population (14). Space does not
permit an expanded discussion of these serious
encroachments on the structural and functional
reserves of the lung, but a few additional com-
ments on COPD are warranted.
A number ofclinical studies (15, 16) have indi-
cated that generally one ofsix (17%) ofthe work-
ing well population have COPD on the basis of
both symptomatology and abnormal pulmonary
function tests. For people in the well population
over the age of 50, it appears that half have
chronic lungdisease. The autopsy, despite the use
of relatively insensitive measurement methods,
has provided strong evidence for substantial lung
reserve depletion. Most pertinently, emphysema-
tous disease in more than trace amounts has been
found to be more often present than absent in the
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lungs ofadults (17-19). Further, Mitchell and his
associates (20) concluded from their studies that
"death certificates from two university medical
center hospitals during a seven year period un-
derstated by about 20% the overall frequency
with which chronic airway obstruction was the
cause of death in subjects older than 40 years,"
and that "the reported death rates for 'emphy-
sema' and 'chronic bronchitis' underestimated the
presence ofchronic airway obstruction atthe time
ofdeath by about 50%." More sensitive methods of
measuring emphysema, and a greater interest in
the support of autopsy studies, will undoubtedly
demonstrateafargreaterlossoflungreservesinthe
well population than presently appreciated (21).
There is a special need for more sensitive pul-
monary function tests as an aid in standard set-
ting. We have speculated, from very limited clini-
copathologic correlations, that pulmonary
function tests first become indicative of chronic
obstructive pulmonary disease (COPD) only
when 50% or more oflung structure and/or func-
tion has been lost, with the loss being largely
irreversible. Germanely, there is no disagree-
ment that a patient who first complains ofsymp-
tomatology referable to COPD may have incurred
as much as 80% or more of irreversible lung
damage. There is also a well-recognized progres-
sive decrement inpulmonary function with aging
(22) that very likely reflects a substantial rate of
consumption ofstructural andfunctional reserves
of the lung. Of further pertinence, experimental
animal studies have shown that 75% ofthe lung
can be extirpated without notably altering the
animal's ordinary activities (23, 34).
The most obvious health implication ofa loss of
lung reserves is a poorer performance, as for
example in competitive sports. More seriously,
reserve loss tends to lower resistance to disease
and leads to a greater vulnerability ofthe lung to
disease in general. Of special pertinence is the
report from the Framingham, Massachusetts
heart study (24, 35) that poor lung function, in
particular forced vital capacity (FVC) was "sec-
ond only to age" as a predictor ofpotential heart
problems and mortality in women, and is rivaled
only by blood pressure among men. It is not clear
whether the low FVC is a sign of generalized
debility or reflects a direct effect of poor lung
function on the heart.
Morbidity and Cardiovascular
Disease
Diseases of the cardiovascular system are the
single greatest cause of death, and exacerbation
of these diseases, e.g., carbon monoxide-induced
myocardial ischemia is an important consider-
ation for air quality standards. Of special inter-
est, Graboys (25) stated that an estimated 40
million Americans will be involved in some form
ofsustained aerobic activityby 1980. Atleasthalf
willbeoverthe age of35 andtherefore candidates
for exercise stress testing. Of the 20 million
asymptomatic individuals in this group, approxi-
mately 10% canbe expectedtohave electrocardio-
graphic changes suggestive of myocardial ische-
mia, thus warranting consideration for coronary
angiography. Ofthe 10% with ECG abnormalities
(2 million persons), 25% or 500,000 will, as a
conservative estimate, have multivessel coronary
disease. Thus there will be half a million candi-
dates for bypass surgery in view ofthe "extrapo-
lated assumption that the asymptomatic person
with multivessel diseases carries an annual mor-
tality similar to that ofthe symptomatic coronary
patient." This illustration of heart disease at a
subclinical level is in accord with routine autopsy
experience. Like destructive lung disease, de-
structive coronary artery disease with some de-
gree ofluminal alteration is the rule and not the
exception at autopsies of adults. It is also not
uncommon to find atheromatous plaque forma-
tion in the young adult, or even in the child.
Germanely, a 1953 report on coronary disease in
soldiers killed in action in Korea stated that
77.3% of 200 soldiers, age 18 to 48 (mean age 22)
had some evidence of coronary arteriosclerosis
(26). In 5.3% ofthe hearts, luminal narrowing of
the artery was over 90%, and complete occlusion
of one or more vessels occurred in 3%. While a
more recent study of 105 U.S. soldiers killed in
Vietnam (18 to 37, mean 22.1 years) showed less
coronary disease (? methodology difference or im-
provement in health), there was nevertheless evi-
dence of some coronary artery atherosclerosis in
45% and severe disease in 5% (27). The fact that
one can live to "a full lifespan" despite a totally
occluded left coronary artery, or in rare instances
with marked occlusion ofboth right and left coro-
nary arteries, largely reflects great reserve capa-
bilities.
Diminished body reserves and increased sub-
clinical disease due to poor air quality will be
eventually reflected in mortality statistics. Need-
less to say, the immediate standard setting need
is to avoid adverse health effects that will lead to
end-stage disease, especially considering that
large segments of the well population will have
sustained substantial covert and irreversible
damage to their health by the time mortality
statistics would indicate the seriousness of the
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poor air quality. Mortality data can, however,
serve a number of important purposes, not the
least ofwhich is providing epidemiologists with a
more precise identification of primary and con-
tributory causes ofdeath. There is a need not only
for improvements in the uniformity ofdeath cer-
tificate recording, considering their flagrant inac-
curacy at the present time (20, 28), but also for a
greater use of the autopsy for verification of the
clinical diagnosis. In a recent review, Wheeler
(29) stated that a reliance on clinical diagnosis
alone results in an overall inaccuracy rate of40%
to 50% for death records, and the error is ofmajor
significance for at least 10% of the records.
Furthermore, there is relatively little apprecia-
tion for the fact that the autopsy itself is com-
monly the source ofmajor error in the interpreta-
tion of the cause of death and contributing
factors. An example of great pertinence to air
quality evaluation is the relatively crude and
nonuniform diagnosis of emphysema at autopsy
(21). More specifically, Thurlbeck (30) has pointed
out that " ... expert pathologists have found
uninflated lungs valueless in recognizing emphy-
sema at necropsy. Even when inflated lungs were
used experts in the pathology of emphysema
showed startling discrepancies in their estimates
ofemphysema . . ."
What Is an Adverse Health Effect?
Noxious air pollutants, and noxious agents in
general, adversely affect the cellular ecology
(cells, tissues, and environs) to produce abnor-
malities ranging from minor perturbations that
are compensable or reversible to totally destruc-
tive lesions and functional abnormalities that
lead to death. It should be emphasized that re-
versible as well as irreversible abnormalities of
relatively minor magnitude can nevertheless
have a serious impact on health by exacerbating
other disease processes or by creating a state of
increased susceptibility to disease in general. To
meet the real needs ofair quality control, special
efforts must be made to increase the sensitivity of
discriminants used for assistance in standard set-
ting, not only with respect to the present empha-
sis on pulmonary function testing and the record-
ing ofacute respiratory disease, but also in terms
of unmasking the greater part of disease and
abnormal function that presently exists at a sub-
clinical level in the well population. Thus, a defi-
nition ofan adverse health effect must encompass
the entire spectrum of disease. We propose the
following definition: an adverse health effect is
the causation, promotion, facilitation, and/or ex-
acerbation of a structural and/or functional ab-
normality, with the implication that the abnor-
mality produced has the potential oflowering the
quality of life, causing a disabling illness, or
leading to a premature death. A special attribute
ofthe definition is the focus on the earliest stage
ofdisease. This can mean detection before covert
disease becomes extensive and widely distributed
in the well population, as for example may very
well be taking place with respect to emphysema
for reasons presently unestablished. In the latter
respect, there is obviously a need to determine
the rate of depletion of lung reserves in the well
population, and to employ animal models in a
search for alterations at the level of the cellular
ecology (discussed further below). The definition
also encourages a search for relatively minor ad-
verse effects on cells andtissues that may serve to
facilitate or otherwise amplify other disease proc-
esses. A cogent example is the facilitation ofcan-
cer metastasis to the lung (as opposed to a role in
the causation or promotion of cancer) by an am-
bient level of an air pollutant, as discussed by
Richters elsewhere in this symposium presenta-
tion. One other relatively overlooked area of
health concern that falls under the covert part of
the adverse health effect definition is the low-
grade, chronic disease process caused by subtle
hypersensitivity type reactions, ofwhich there is
a rapidly growing and still relatively unappreci-
ated list of responsible agents (10), and also by
relatively unappreciated infectious diseases that
are caused by diverse organisms indigenous to
the lungs and other organs (discussed below).
The Endogenous Infectivity
Experimental Animal Model
Presently, the infectivity animal model, based
on exposing animals to aerosols ofhighly concen-
trated bacterial populations (31), is receiving spe-
cial attention for its high level of sensitivity in
demonstrating an adverse effect of air pollution.
The end point ofthe testing is a greater incidence
ofmortality in the pollutant exposed group com-
pared to the number of deaths in the control
group ofanimals. Recently, an animal model sys-
tem has been developed that addresses the oppo-
site end of the infection spectrum, namely the
facilitation of expression of infectious organisms
that are indigenous to the lung. In an earlier
study, a phenomenon of delayed outgrowth of
pseudomonas aeruginosa was observed in tissue
cultures ofthe lungs ofguinea pigs that had been
exposed to NO2 (32). More recently, viral RNA
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has been found to be increased in the spleens of
mice exposed to ambient levels of NO2 (33). Of
related interest, spleen weights of N02-exposed
mice initially increase then fall below normal
(34). There may also be a relationship between
the expression ofretrovirus in lung cells and the
occurrence ofan increase in macrophage interac-
tionswithlungcells (35,36). Thepotential impor-
tance ofthe endogenous infectivity model is that
it can provide data on the mechanisms involved
in the facilitation ofvirus expression by poor air
quality. Germanely, the opportunistic expression
ofinfectious organisms ofdiverse kinds in human
lungs is a growing health hazard due to immune
deficiency conditions that are not well under-
stood, e.g., the recently identified syndrome of
acquired immune deficiency related to blood con-
tact, hepatitis, drugs and other factors (37).
Among the opportunistic organisms commonly
involved in human lung disease are cytomega-
lovirus, herpes simplex, pneumocystis carinii,
and candida.
Pollutant-induced Alteration of
the Cellular Ecology of the Mouse
Lung
A number of studies have been carried out in
this laboratory to determine the influence ofam-
bient levels ofNO2 and ozone, singly and in com-
bination, on the Type 2 cell ofthe guinea pig and
mouse alveolus. In two ofthe most recent investi-
gations, adult Swiss-Webster mice were exposed
to either 0.34 ppm NO2 or to 0.3 ppm ozone, the
exposures being intermittent (7 hr/day, 5 days/
week) for 6 weeks, after which the very strongly
lactate dehydrogenase positive Type 2 cells were
quantitated by computer-assisted image analysis.
The measurements included number of Type 2
cells, their area, the area and perimeters of the
alveolarwalls, andotherparameters. An increase
in Type 2 cells that was statistically significant
forthe NO2 and ozone exposed animals was found
(38, 39). Further, unpublished data indicate that
the influence ofNO2 on the response ofthe Type 2
cell, including alteration in size as well as num-
ber, had not reversed at the longest postexposure
period so far evaluated, i.e., 10 weeks after a 6-
week NO2 exposure period (40). An apparent pro-
tein leakage has also been found (41). The signifi-
cance of the Type 2 cell hyperplasia is that
damage and loss ofType 1 cells is followed by an
increase in the Type 2 cell, the progenitor cell for
the Type 1 cell. Since the loss of substantial
numbers of alveoli is common to essentially all
human adult lungs, and since Type 2 cell hyper-
plasia is an early and common denominator type
event for human lung disease in general, the
ultimate requirement for answering the question
ofreversibility ofType 2 cell hyperplasia in both
the human and animal model lung is an inven-
tory ofalveoli. Infact, we consider an inventory of
alveoli in the lungs of the well population (pri-
marily from coroner cases) to be the single great-
est need for assistance inthe settingofreasonable
air quality standards. A monitoring ofreserves is
in line with the cardinal principle ofconservation
ofthe ecology in general. The protection ofhuman
health must be extended to include the ecology at
the cellular level.
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